Delivery Order V797D70255-36C24526N0834
Award Date 8/25/26
Potential Completion Date 8/27/26
Potential Value $17K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Carrollton, TX 75010, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Veterans Integrated Service Network 22 issued a $50,880 delivery order to Galderma Laboratories, L.P. on July 30, 2026, for emergency supply of Nemluvio 30 mg (nemolizumab) injectable pharmaceutical products under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Place of performance is Carrollton, TX. The order is firm fixed price with an ultimate completion date of July 29, 2027. No set-aside was used. Galderma supplies injectable pharmaceutical products to the VA...
- The Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5) awarded a delivery order valued at $31,800 to Galderma Laboratories, L.P. for the supply of Nemluvio 30 mg, an injectable pharmaceutical product. The contract was awarded on March 18, 2026, with an ultimate completion date of March 20, 2026, reflecting the time-sensitive nature of pharmaceutical supply to VA healthcare operations. This delivery order operates under a firm fixed-price arrangement with no...
- Galderma Laboratories, L.P. was awarded a delivery order valued at $46,697.40 by Veterans Integrated Service Network 5 (VISN 5), a civilian agency within the Department of Veterans Affairs, for the supply of NEMLUVIO 30 mg pharmaceutical product. The contract, awarded on September 19, 2025, with an ultimate completion date of September 23, 2025, operates under a firm fixed-price arrangement with no set-aside designation. The delivery order was placed through the Pharmaceuticals and Drugs Federal...
- The Defense Logistics Agency issued a $2,033.08 delivery order to Amerisourcebergen Drug Corp on May 19, 2026, for Nemluvio 30 mg pens, with an ultimate completion date of June 10, 2026. Place of performance is Conshohocken, PA. The order is priced on a firm fixed-price basis with no set-aside. This delivery order represents a transactional pharmaceutical supply call within Amerisourcebergen's broader role as a pharmaceutical distributor and medical supplier to Defense Health Agency and military...
- The Defense Logistics Agency issued a $4,066.16 delivery order to AmerisourceBergen Drug Corp on April 7, 2026, for 30 mg Nemluvio pens, with final completion due April 28, 2026. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (valued at $999,999,999.00 through December 2026), which supplies pharmaceutical products and medical commodities to support military healthcare programs worldwide. Place of performance is Conshohocken, PA. The order carries firm...
- The Defense Logistics Agency issued a $2,033.08 delivery order to AmerisourceBergen Drug Corp on April 9, 2026, for 30 mg Nemluvio pens, with a completion date of April 30, 2026. Place of performance is Conshohocken, PA. The order is priced on a firm fixed price basis with no set-aside applied. This delivery order is issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December...
- <p>The Defense Logistics Agency issued a $2,033.08 delivery order to AmerisourceBergen Drug Corp on April 16, 2026, for Nemluvio 30 mg pens, with final delivery due May 7, 2026.</p> <p>Place of performance is Conshohocken, PA. The order is firm fixed price with no set-aside.</p>
- The Defense Logistics Agency issued a $4,066.16 delivery order to AmerisourceBergen Drug Corp on February 18, 2026, for Nemluvio 30 mg pens. The order is issued under a parent Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 and running through December 2026, which provides global pharmaceutical support across multiple therapeutic domains to military healthcare programs. Place of performance is Conshohocken, PA. Ultimate completion date is March 11,...
- <p>The Defense Logistics Agency issued a $2,033.08 delivery order to AmerisourceBergen Drug Corp on March 5, 2026, for Nemluvio 30 mg pens, with ultimate completion by March 26, 2026.</p> <p>The order is issued under the company's Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999 global pharmaceutical supply vehicle running through December 2026. Place of performance is Conshohocken, PA. The order carries firm fixed pricing and no set-aside.</p>
- The Defense Logistics Agency issued a $2,033.08 delivery order to AmerisourceBergen Drug Corp on March 9, 2026, for Nemluvio 30 mg pens, with an ultimate completion date of March 30, 2026. This is a firm fixed-price delivery order with no set-aside. Place of performance is Conshohocken, PA. The order is issued under the DLA Troop Support Medical Indefinite Delivery Contract (IDC) valued at $999,999,999.00 and running through December 2026, which serves as the primary vehicle for pharmaceutical...
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- V797D70255Federal Supply Schedule
- V797D70255-36C24526N0834Delivery Order
The Department of Veterans Affairs, Veterans Integrated Service Network 5, issued a $16,960 delivery order to Galderma Laboratories, L.P. on August 25, 2026, for Nemluvio 30 mg pharmaceutical supply. The order is placed under the GSA Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Place of performance is Carrollton, TX. The order carries a firm fixed price structure with an ultimate completion date of August 27, 2026. No set-aside was used.
Generated 8/26/26, 9:43 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.0k | 8/24/26 |